Real-World Safety and Effectiveness of Up to 12 Months of Tralokinumab Treatment in Adults With Atopic Dermatitis Who Discontinued Dupilumab Due to Conjunctivitis. J of Skin. 2026;10(2):s729. doi:10.25251/1jtrf706